These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34689597)

  • 1. Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection.
    Asif M; Saleem M; Yaseen HS; Yehya AH; Saadullah M; Zubair HM; Oon CE; Khaniabadi PM; Khalid SH; Khan IU; Mahrukh
    Future Microbiol; 2021 Nov; 16(16):1289-1301. PubMed ID: 34689597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations.
    Vishvakarma VK; Singh MB; Jain P; Kumari K; Singh P
    Amino Acids; 2022 Feb; 54(2):205-213. PubMed ID: 34807314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.
    Rahman MM; Islam MR; Shohag S; Hossain ME; Shah M; Shuvo SK; Khan H; Chowdhury MAR; Bulbul IJ; Hossain MS; Sultana S; Ahmed M; Akhtar MF; Saleem A; Rahman MH
    Environ Sci Pollut Res Int; 2022 Jul; 29(31):46527-46550. PubMed ID: 35507224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.
    El Hassab MA; Hemeda LR; Elsayed ZM; Al-Rashood ST; Abdel-Hamid Amin MK; Abdel-Aziz HA; Eldehna WM
    Chem Biodivers; 2022 Feb; 19(2):e202100719. PubMed ID: 34813168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model.
    Alsaidi S; Cornejal N; Mahoney O; Melo C; Verma N; Bonnaire T; Chang T; O'Keefe BR; Sailer J; Zydowsky TM; Teleshova N; Romero JAF
    Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytochemicals for the treatment of COVID-19.
    Españo E; Kim J; Lee K; Kim JK
    J Microbiol; 2021 Nov; 59(11):959-977. PubMed ID: 34724178
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    El Gizawy HA; Boshra SA; Mostafa A; Mahmoud SH; Ismail MI; Alsfouk AA; Taher AT; Al-Karmalawy AA
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an
    Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM
    Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
    White KM; Rosales R; Yildiz S; Kehrer T; Miorin L; Moreno E; Jangra S; Uccellini MB; Rathnasinghe R; Coughlan L; Martinez-Romero C; Batra J; Rojc A; Bouhaddou M; Fabius JM; Obernier K; Dejosez M; Guillén MJ; Losada A; Avilés P; Schotsaert M; Zwaka T; Vignuzzi M; Shokat KM; Krogan NJ; García-Sastre A
    Science; 2021 Feb; 371(6532):926-931. PubMed ID: 33495306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.
    Ahmed MN; Jahan R; Nissapatorn V; Wilairatana P; Rahmatullah M
    Biomed Pharmacother; 2022 Feb; 146():112507. PubMed ID: 34891122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis.
    Sachse M; Tenorio R; Fernández de Castro I; Muñoz-Basagoiti J; Perez-Zsolt D; Raïch-Regué D; Rodon J; Losada A; Avilés P; Cuevas C; Paredes R; Segalés J; Clotet B; Vergara-Alert J; Izquierdo-Useros N; Risco C
    Antiviral Res; 2022 Apr; 200():105270. PubMed ID: 35231500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
    Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
    Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
    Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
    Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
    Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
    Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
    Maurya DK; Sharma D
    J Biomol Struct Dyn; 2022 Jun; 40(9):3949-3964. PubMed ID: 33251972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Docking of Phytochemical Compounds of Momordica charantia as Potential Inhibitors against SARS-CoV-2.
    Evary YM; Masyita A; Kurnianto AA; Asri RM; Rifai Y
    Infect Disord Drug Targets; 2022; 22(3):e130122200221. PubMed ID: 35049440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
    Aguareles J; Villares Fernández P; Forné C; Martí-Ballesteros EM; Pradillo Fernández V; Sotres-Fernandez G; de la Fuente-Burguera A; Navarro-San Francisco C; Buzón-Martín LM; García-Delangue T; Aiello FT; Carnevali-Ruiz D; Lloris R; Luepke-Estefan XE; López-Martín JA; Jimeno JM; García-Casas A; Guisado-Vasco P
    Infect Dis (Lond); 2024 Jul; 56(7):575-580. PubMed ID: 38743059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Hopes for Drugs against COVID-19 Come from the Sea.
    Taglialatela-Scafati O
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33670191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.